Welcome to the New Value Research! Two routes to the Nifty 50 What Small Caps Actually Pay You For 10 promising new funds The three-year wait The fund that missed 2025 and came back stronger Four international funds are open again. Here is the list Buying the fund house Best AMC stock to invest in Retiring in 8 years. Go direct now? Eleven stocks look better on paper and still trade cheap Multi-asset funds share a name, not a portfolio 10 PSU banks look cheap. Market is asking a fair question One international fund takes lump sums. Four take SIPs Only 7% of life insurance payouts are death claims NPS Swasthya: buy the cover, not the corpus The next scam will not look like a scam The final layer is human Finolex Cables vs RR Kabel: Same sector, different paths Two global funds take lump sums. The Nasdaq Q50 costs double Policyholders win 63% of complaints against insurers Loan Against Mutual Funds: Good or Bad? You chose 60:40. The market made it 75:25 Tata Capital did everything right. The stock went nowhere Your emergency fund is not part of your 60-40 What changed inside India's insurance regulator? Tonbo Imaging: clear sights, cloudy financials 75 per cent Stocks After Retirement: Time to Switch? Bonfiglioli Transmissions: Gearbox leader on Italy's terms What your stock's P/E is actually betting on YES Bank's Rs 8,415 crore problem: Can it absorb the blow? Few international funds are open. Domestic funds may help Buying gold on Dhanteras is not investing A year on, LG's price has run ahead of its profit Jio Platforms: What will drive its next phase of growth? Paras Healthcare IPO: paying today for tomorrow's hospitals Is Your Fund Good? Here's How to Check Shadowfax: From a weak listing to a threefold rally Ambuja vs UltraTech: the battle to turn capacity into profit Six international funds end old SIPs. Five take new money